Your session is about to expire
← Back to Search
Procedure
Treatment for Atrial Fibrillation (COAST-AF Trial)
N/A
Waitlist Available
Led By Pablo B Nery, MD
Research Sponsored by Ottawa Heart Institute Research Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
COAST-AF Trial Summary
This trial is testing a new way to map and treat atrial fibrillation, which if successful, could result in higher success rates for treating the condition.
Eligible Conditions
- Atrial Fibrillation
COAST-AF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Atrial Fibrillation (AF) Termination
Secondary outcome measures
Freedom from AF
Procedure Duration
Radio frequency (RF) ablation time
Find a Location
Who is running the clinical trial?
Ottawa Heart Institute Research CorporationLead Sponsor
188 Previous Clinical Trials
92,384 Total Patients Enrolled
23 Trials studying Atrial Fibrillation
6,639 Patients Enrolled for Atrial Fibrillation
Pablo B Nery, MDPrincipal InvestigatorOttawa Heart Institute Research Corporation
Robert deKemp, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You cannot take medication to prevent blood clots.You have a condition called atrial fibrillation, but it can be treated and reversed.You have ongoing symptoms of atrial fibrillation and your doctor recommends a procedure to treat it.You have had a procedure to treat atrial fibrillation in the past.There is a blood clot inside the heart.Your heart's left atrium is too big on an echocardiogram, measured from front to back.You have experienced an episode of AF (atrial fibrillation) lasting more than 7 days within the past year, and it has been confirmed by different types of heart monitoring tests.You have a serious problem with one of your heart valves.You have long-term kidney disease and your kidneys do not filter blood well.You are between 18 and 80 years old.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the research require participants to meet a particular age criterion?
"As indicated by the selection criteria, this clinical trial is open to applicants who are of legal age (18) or older but not beyond 80 years."
Answered by AI
Would I qualify to join this experiment?
"To qualify for this trial, participants must have atrial fibrillation and be between 18 to 80 years old. The team is currently seeking out 52 individuals."
Answered by AI
Are there still opportunities for individuals to join this medical experiment?
"The most recent available information from clinicaltrials.gov states that this medical trial, which began in August 2015 and was last edited on March 3rd 2023, is not actively seeking new patients at present; however, there are presently 499 other trials looking for candidates to join them."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger